Skip to main content
. 2021 Dec 23;14(1):47. doi: 10.3390/cancers14010047

Figure 3.

Figure 3

Expression levels of CTC-associated markers in blood samples of CRC patients with different tumor stages, IID patients and healthy controls. MNC-derived cDNA from n = 98 CRC patients, n = 64 IID patients and n = 40 healthy controls was analyzed by RT-qPCR for expression of (A) CK20, (B) PLS3, (C) LAD1, and (D) DEFA5. CRC patients were divided in patients with early-stage cancer (UICC I/II) and late-stage cancer (UICC III/IV). Data are presented as median and 95% confidence interval. ** p < 0.01; *** p < 0.001.